Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05858801

First Evaluation of a Craniofacial Peripheral Nerve Stimulation System in Chronic Migraine

First Evaluation of a Craniofacial Peripheral Nerve Stimulation System in Chronic Migraine, an Early Feasibility Study

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
7 (actual)
Sponsor
Salvia BioElectronics · Industry
Sex
All
Age
18 Years – 84 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to demonstrate the safe use of the PRIMUS system in subjects with chronic migraine. This is a single-center, open label, prospective, early feasibility study to collect initial clinical data on the PRIMUS system for the treatment of chronic migraine.

Conditions

Interventions

TypeNameDescription
DEVICEPRIMUSPRIMUS system

Timeline

Start date
2023-05-09
Primary completion
2023-12-09
Completion
2026-01-31
First posted
2023-05-15
Last updated
2024-05-16

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT05858801. Inclusion in this directory is not an endorsement.

First Evaluation of a Craniofacial Peripheral Nerve Stimulation System in Chronic Migraine (NCT05858801) · Clinical Trials Directory